scholarly journals COEXISTENT HYPERTROPHIC CARDIOMYOPATHY AND OBSTRUCTIVE SLEEP APNEA INCREASE THE RISK OF ARRHYTHMIA RECURRENCE FOLLOWING CATHETER ABLATION OF ATRIAL FIBRILLATION

2016 ◽  
Vol 67 (13) ◽  
pp. 852
Author(s):  
Sanghamitra Mohanty ◽  
Prasant Mohanty ◽  
Chintan Trivedi ◽  
Carola Gianni ◽  
Amin Al-Ahmad ◽  
...  
2020 ◽  
Vol 2 (9) ◽  
pp. 507-516
Author(s):  
Hiroshi Kawakami ◽  
Makoto Saito ◽  
Satoshi Kodera ◽  
Akira Fujii ◽  
Takayuki Nagai ◽  
...  

2013 ◽  
Vol 62 (4) ◽  
pp. 300-305 ◽  
Author(s):  
Adam S. Fein ◽  
Alexei Shvilkin ◽  
Dhaval Shah ◽  
Charles I. Haffajee ◽  
Saumya Das ◽  
...  

2008 ◽  
Vol 19 (7) ◽  
pp. 668-672 ◽  
Author(s):  
KRIT JONGNARANGSIN ◽  
AMAN CHUGH ◽  
ERIC GOOD ◽  
SIDDHARTH MUKERJI ◽  
SUJOYA DEY ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
N Tanaka ◽  
K Inoue ◽  
K Tanaka ◽  
Y Hirao ◽  
T Oka ◽  
...  

Abstract Background Catheter ablation of atrial fibrillation (AF) is effective, but certain patients experience AF recurrences. Obstructive sleep apnea (OSA) is a risk factor for AF recurrence. Watch peripheral arterial tonometry (WP) has a good correlation with polysomnography (PSG) in terms of the apnea-hypopnea index (AHI) and is easier to perform than PSG. Patients in AF have a high prevalence of OSA. Whether all patients with AF should be evaluated for OSA before catheter ablation is still controversial. Purpose To elucidate the prevalence and predictors of OSA using WP as a home sleep apnea test in AF patients before catheter ablation. Methods This study was conducted under a retrospective, single-center, observational design. Patients who received AF ablation without a prior diagnosis of sleep apnea and assessment of their AHI using WP were included in this analysis. The patients were mounted with a WP device by themselves at their own home. Twenty-two patients who were already diagnosed with OSA were excluded. Results Seven hundred seventy-four (65±11 years, 567 males, 440 paroxysmal AF) out of 776 patients were successfully mounted with WP devices on their own and underwent an OSA assessment. Their mean body mass index (BMI) was 24.1±3.5 kg/m2. The mean AHI was 20.1±15.6. Only 88 (11.4%) patients had a normal AHI (AHI<5). Mild OSA (5≤AHI<15), moderate OSA (15≤AHI<30), and severe OSA (AHI≥30) were observed in 274 (35.4%), 252 (32.6%), and 160 (20.7%) patients, respectively. A BMI≥25 (odds ratio [OR]; 2.42, 95% confidence interval [CI]; 1.74–3.37, p<0.001), male sex (1.70, 1.19–2.44, p=0.0037), non-paroxysmal AF (1.90, 1.35–2.66, p=0.0002), hypertension (1.70, 1.24–2.33, p=0.009), and left atrial volume index ≥30 (OR=1.51, CI 1.06–2.16, p=0.022) were significant predictors of moderate or severe OSA by a multivariate analysis, while an Epworth sleepiness scale ≥11 was not a predictor of moderate or severe OSA (OR=0.99, CI 0.66–1.49, p=0.95). However, 44.2% of non-obese patients (BMI <25) had moderate-severe OSA. Conclusion Almost All patients successfully underwent WP to diagnose OSA. AF patients had a high prevalence of OSA, and screening OSA would be important in AF patients receiving ablation even if patients do not have sleepiness or are obese. We cannot deny OSA in AF patients before catheter ablation without performing screening tests for OSA. Funding Acknowledgement Type of funding source: None


Sign in / Sign up

Export Citation Format

Share Document